(Q68443393)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

meta-analysis

0 references

title

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

author name string

G Alván

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

P Bechtel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

L Iselius

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

U Gundert-Remy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

533-537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00316090

24 September 2019

exact match

0 references

cites work

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

12 December 2020

Enzyme diversity in human populations

1 reference

12 December 2020

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

1 reference

12 December 2020

Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma

1 reference

12 December 2020

The debrisoquin hydroxylation phenotype does not predict the metabolism of phenytoin

1 reference

12 December 2020

Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians

1 reference

12 December 2020

Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation

1 reference

12 December 2020

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

12 December 2020

The influence of enzyme induction on polymorphic sparteine oxidation

1 reference

12 December 2020

Sparteine oxidation polymorphism in Denmark.

1 reference

12 December 2020

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

1 reference

12 December 2020

Phenotyping polymorphic drug metabolism in the French Caucasian population

1 reference

12 December 2020

Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese

1 reference

12 December 2020

[A survey of debrisoquin hydroxylation polymorphism]

1 reference

12 December 2020

[Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments]

1 reference

12 December 2020

Prevalence of drug hydroxylator phenotypes in Belgium

1 reference

12 December 2020

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

12 December 2020

Proceedings: N-oxidation of sparteine in man and its interindividual differences

1 reference

12 December 2020

Genetic control of isoniazid metabolism in man

1 reference

12 December 2020

Inhibitory effects of neuroleptics on debrisoquine oxidation in man

1 reference

12 December 2020

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

1 reference

12 December 2020

Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Comparative pharmacogenetics of sparteine and debrisoquine

1 reference

12 December 2020

Polymorphism of debrisoquine hydroxylation among Finns and Lapps

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Polymorphism of dextromethorphan oxidation in a French population

1 reference

12 December 2020

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

1 reference

12 December 2020

Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark

1 reference

12 December 2020

Drug hydroxylator phenotype in Hungary

1 reference

12 December 2020

Debrisoquin oxidation polymorphism in a Spanish population

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Balanced pharmacokinetics and metabolism of bisoprolol

1 reference

12 December 2020

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00316090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2151318%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference